Resultados de la búsqueda 861-870 of 1942 for decrease distributed program

  1. Neurología - Ensayos clínicos

    ... decline. A Registry Called Every Child for Collecting Data and Biology ... A Study of the Brain & Body Donation Program. Scottsdale/Phoenix, Ariz. The ...

  2. Cáncer de mama - Médicos y departamentos - Mayo Clinic

    Women's Cancer Program. El Programa para el Cáncer Femenino de Mayo Clinic reúne a médicos e investigadores de cirugía mamaria y ginecológica, oncología ...

  3. Enfermedad de Alzheimer - Médicos y departamentos - Mayo Clinic

    Infórmate más sobre este trastorno cerebral, que es la causa más común de demencia. Además, infórmate sobre nuevas pruebas y medicamentos a la venta.

  4. Ensayos clínicos - Neurología

    To establish a repository of DNA samples collected prospectively from patients with inherited myopathies of unknown molecular and/or biochemical defect.

  5. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to evaluate the safety and tolerability and determine the recommended Phase 2 dose (RP2D) of YH001 when given with envafolimab ...

  6. Neurología - Ensayos clínicos

    ... decline. A Study to Evaluate Electrophysiology of Deep Brain Stimulation ... A Study of the Brain & Body Donation Program. Scottsdale/Phoenix, Ariz. The ...

  7. Oncología (médica) - Ensayos clínicos

    Usual treatment after a complete response may include observation or high dose chemotherapy followed by an autologous stem cell transplant, however, it is not ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  9. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to determine the safety and feasibility of intra-operative Ommaya Reservoir placement during a clinically indicated tumor ...

  10. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to determine whether there is an increase in the time of a first occurrence of either: local recurrence, leptomeningeal disease ...